As an emerging method for detecting unique signals from the molecules of interest, magnetic resonance spectroscopy (MRS)[7] identifies IDH1 mutation by tracking D‐2‐hydroxyglutarate (D‐2HG), an oncometabolite of IDH1‐MUT glioma cells. Here, IDH1 is linked to glioma.